Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Communications Biology
|
November 18, 2025
Assessing gut microbial provisioning of essential amino acids to host in a mouse model with reconstituted gut microbiomes
Paul Ayayee, Gordon Custer, Jonathan Brent Clayton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 13, 2026
Next-generation Alzheimer's therapeutics: target assessment and enablement at the Indiana University School of Medicine-Purdue University TREAT-AD Center
Timothy I Richardson, Rebecca C Klein, Kun Huang, et al.
Plos One
|
March 29, 2024
A novel micellular fluorogenic substrate for quantitating the activity of 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma (PLCγ) enzymes
Ramya Visvanathan, Tadanobu Utsuki, Daniel E Beck, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 30, 2026
From consortia discovery to biotech creation: An innovative approach to next-gen Alzheimer's drugs
Sarah F Giardina, Alexander Culver, Chandrama Ahmed, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 25, 2026
Evaluation of ASC as a therapeutic target for Alzheimer's disease
W Brent Clayton, Joshua A Kulas, Jiahui Liu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Brent Clayton, Steven M Massey, Shaoyou Chu, et al.
Journal of Medicinal Chemistry
|
March 12, 2015
Lead optimization toward proof-of-concept tools for Huntington's disease within a 4-(1H-pyrazol-4-yl)pyrimidine class of pan-JNK inhibitors
John Wityak, Kevin F McGee, Michael P Conlon, et al.
Biorxiv : the Preprint Server for Biology
|
January 9, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease Models
Cynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Journal of Medicinal Chemistry
|
April 30, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease Models
Cynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Communications Biology
|
November 18, 2025
Assessing gut microbial provisioning of essential amino acids to host in a mouse model with reconstituted gut microbiomes
Paul Ayayee, Gordon Custer, Jonathan Brent Clayton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 13, 2026
Next-generation Alzheimer's therapeutics: target assessment and enablement at the Indiana University School of Medicine-Purdue University TREAT-AD Center
Timothy I Richardson, Rebecca C Klein, Kun Huang, et al.
Plos One
|
March 29, 2024
A novel micellular fluorogenic substrate for quantitating the activity of 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma (PLCγ) enzymes
Ramya Visvanathan, Tadanobu Utsuki, Daniel E Beck, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 30, 2026
From consortia discovery to biotech creation: An innovative approach to next-gen Alzheimer's drugs
Sarah F Giardina, Alexander Culver, Chandrama Ahmed, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 25, 2026
Evaluation of ASC as a therapeutic target for Alzheimer's disease
W Brent Clayton, Joshua A Kulas, Jiahui Liu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Brent Clayton, Steven M Massey, Shaoyou Chu, et al.
Journal of Medicinal Chemistry
|
March 12, 2015
Lead optimization toward proof-of-concept tools for Huntington's disease within a 4-(1H-pyrazol-4-yl)pyrimidine class of pan-JNK inhibitors
John Wityak, Kevin F McGee, Michael P Conlon, et al.
Biorxiv : the Preprint Server for Biology
|
January 9, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease Models
Cynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Journal of Medicinal Chemistry
|
April 30, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease Models
Cynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Page
of 1